the prescribed Lanoxin dose, several months, as part of a heart-failure plan. He reported better control of his resting pulse, but felt light-headed during a stomach illness and needed prompt medical review.
Lanoxin tablets are taken by mouth, with the dose and schedule selected for the individual patient. It can strengthen cardiac contraction and slow electrical conduction through the atrioventricular node, while requiring careful monitoring because the therapeutic margin is narrow.
Overview
Lanoxin is a brand name for digoxin. Digoxin belongs to the cardiac glycoside class and is also described as an Antiarrhythmic Agent when used for ventricular-rate control in selected supraventricular rhythms. The active substance is also called DIGOXINE in some medical and regulatory materials.
Dosage and administration
How much to use and how often depends on the purpose of use and is agreed with a doctor or pharmacist. There is no universal Adult Dose that is appropriate for every patient.
- Take the prescribed Lanoxin Tablet by mouth at consistent times.
- Use the prescribed strength rather than copying another patient’s dose.
- Take Lanoxin oral drops only with an accurate measuring device.
- Do not double the next dose after a missed dose.
- If a missed dose is remembered close to the next scheduled dose, the missed dose is generally omitted rather than taken together with the next one.
- Do not start a loading dose without direct clinical instruction.
- Do not increase a maintenance dose because symptoms have not improved quickly.
Loading and Maintenance Regimens
A clinician-directed loading dose may be used in selected circumstances, including some cases of Atrial Fibrillation. Loading doses are not suitable for everyone and can increase toxicity if prior digoxin exposure is overlooked.
A maintenance dose is the ongoing dose after treatment has been established. Adjustments may be considered after clinical review, sometimes at intervals such as two weeks, but the patient should not make those changes independently. The decision is based on clinical response, symptoms, kidney function, electrolytes and toxicity risk.
Missed Doses and Safe Administration
Consistent timing reduces accidental duplication. If vomiting occurs soon after a dose, do not automatically repeat it; repeated dosing can create an unintended excess.
Digoxin Level Monitoring
Digoxin levels in blood are interpreted alongside symptoms, ECG findings, kidney function and electrolytes. A serum digoxin level is not a stand-alone safety score. The timing of blood collection relative to the last dose also affects interpretation.
Formulation
Lanoxin is a brand name for digoxin. Digoxin belongs to the cardiac glycoside class and is also described as an Antiarrhythmic Agent when used for ventricular-rate control in selected supraventricular rhythms. The active substance is also called DIGOXINE in some medical and regulatory materials.
Its two main cardiovascular actions are:
- Increasing the force of cardiac contraction.
- Slowing electrical conduction through the atrioventricular node.
The first action can help the heart pump blood with greater efficiency in selected patients with heart failure. The second can reduce the speed at which impulses reach the ventricles during atrial fibrillation or atrial flutter. Lanoxin does not convert every abnormal rhythm back to a normal rhythm.
Digoxin Mechanism of Action
Digoxin inhibits the sodium-potassium ATPase pump in cardiac cells. This increases intracellular calcium availability, strengthening myocardial contraction. It also increases vagal activity, which slows conduction through the atrioventricular node.
The same pharmacology that produces benefit can contribute to toxicity when digoxin concentrations become excessive. Kidney function, age, body size, hydration, electrolyte balance and interacting medicines can all influence exposure.
Clinical Role of Lanoxin
Lanoxin may be prescribed as part of a selected heart-failure regimen or for ventricular-rate control in atrial fibrillation and atrial flutter. In clinical practice, the decision depends on symptoms, ejection fraction, kidney function, blood pressure, rhythm characteristics and other medicines.
Rate control is different from rhythm conversion. A slower pulse does not necessarily mean that atrial fibrillation or atrial flutter has disappeared.
How it affects the body
Digoxin inhibits the sodium-potassium ATPase pump in cardiac cells. This increases intracellular calcium availability, strengthening myocardial contraction. It also increases vagal activity, which slows conduction through the atrioventricular node.
Therapeutic indications
Lanoxin Tablets may be used for selected patients with Heart failure and for ventricular-rate control in Supraventricular arrhythmias. Common rhythm-related contexts include Atrial fibrillation and Atrial flutter. The Canadian indication and instructions should follow the applicable Health Canada product monograph [1].
| Clinical situation | Intended effect | What Lanoxin does not address |
|---|---|---|
| Heart failure | Supports cardiac contraction in selected treatment plans | It does not remove every cause of heart failure |
| Atrial fibrillation | Slows ventricular response in selected patients | It does not automatically restore normal rhythm |
| Atrial flutter | Helps control ventricular rate in selected cases | It does not replace stroke-prevention treatment |
Lanoxin in Heart Failure
Treatment decisions depend on the type and severity of heart failure, ejection fraction, symptoms, kidney function and concurrent therapies. Digoxin may be considered when symptom control or additional rate control is needed within a broader treatment plan.
The response is assessed clinically. Changes in exercise tolerance, swelling, breathlessness, heart rate, kidney function and electrolytes may all matter.
Lanoxin in Atrial Fibrillation and Atrial Flutter
Lanoxin can slow ventricular conduction in selected patients with Atrial fibrillation or Atrial flutter. It may be less suitable as the only rate-control approach when symptoms are driven by exertion, because its rate-lowering effect can differ between rest and activity.
Lanoxin does not replace anticoagulation when stroke prevention is indicated. The need for anticoagulation depends on individual stroke and bleeding risk, not simply on whether the pulse feels slower.
Common mistakes
Patients can reduce avoidable risk by avoiding these mistakes:
- Taking a second dose after forgetting the first.
- Replacing one tablet strength with another.
- Starting a supplement without medication review.
- Treating repeated vomiting as an unrelated stomach problem.
- Using a household spoon for oral drops.
- Assuming a slower pulse proves the rhythm disorder is cured.
- Stopping Lanoxin suddenly when symptoms improve.
- Failing to mention a new antibiotic, heart medicine or diuretic.
Cochrane evidence on digoxin in heart failure also supports careful interpretation of benefit within the wider treatment plan [2].
Reasons not to use it
Lanoxin is not for you if you have a known allergy to digoxin or to an ingredient in the prescribed formulation, or if you have previously had a serious reaction to a cardiac glycoside. Certain rhythm disorders also require specialist assessment before treatment.
Formal contraindications and warnings depend on the Canadian product monograph. ECG assessment, clinical history and medication reconciliation help determine whether Lanoxin is appropriate.
Allergy and Rhythm Precautions
Do not take Digoxin after a known serious allergic reaction to digoxin or a formulation ingredient. Urgent review is needed for suspected toxicity, a new severe rhythm symptom or unreviewed duplicate use of another cardiac glycoside.
When this is not for you
Reduced kidney function can increase exposure even when the prescribed amount has not changed. Diuretic-related changes in potassium or magnesium can also alter toxicity risk.
Before treatment, disclose kidney disease, previous rhythm problems, electrolyte abnormalities, pregnancy status and every medicine or supplement being used.
Possible side effects
Lanoxin Tablet side effects can include nausea, vomiting, diarrhea, dizziness and visual disturbances. These symptoms can also occur during digoxin toxicity, so their intensity, timing and combination matter.
| Reportable effects | Urgent warning signs |
|---|---|
| Nausea, vomiting, diarrhea or dizziness | Fainting, collapse or severe weakness |
| New visual disturbances | Severe palpitations or a very irregular pulse |
| Unusual fatigue or reduced appetite | Confusion, repeated vomiting or suspected overdose |
Common Gastrointestinal and Neurological Effects
Nausea, vomiting, diarrhea and dizziness may occur during treatment. Repeated vomiting or diarrhoea is more concerning when it prevents regular dosing or causes dehydration. Persistent symptoms require prompt medical assessment because dehydration can change digoxin exposure. Dizziness may reflect several causes, including a slow pulse, low blood pressure, rhythm disturbance or toxicity. Do not assume that dizziness is harmless simply because the prescribed dose has not changed.
Visual Disturbances and Other Reportable Effects
Visual disturbances may include blurred vision, altered colour perception or unusual visual patterns. One symptom alone does not establish toxicity, but new visual changes should be reported promptly.
Seek urgent medical assessment for fainting, severe palpitations, collapse, confusion, marked weakness, repeated vomiting or a very slow or irregular pulse. Do not stop long-term cardiac treatment independently unless an urgent clinician instructs you to do so.
Comparison
Lanoxin, beta blockers, selected calcium channel blockers and rhythm-control treatments act through different mechanisms. The best choice depends on heart-failure type, blood pressure, exercise-related symptoms, kidney function, rhythm characteristics and other medicines.
| Option | Main action and common role | Key limitation |
|---|---|---|
| Digoxin | Slows AV-node conduction and increases contraction force; selected heart failure or rate-control use | Narrow therapeutic margin and interaction burden |
| Beta blockers | Reduce heart rate and sympathetic stimulation | May worsen fatigue, low blood pressure or acute decompensated heart failure |
| Selected calcium channel blockers | Slow AV-node conduction in suitable patients | May be unsuitable in some heart-failure types or with low blood pressure |
Rate-Control and Rhythm-Control Distinction
Rate-control treatment reduces the speed of ventricular contraction. Rhythm-control treatment aims to restore or maintain a more regular rhythm. An Antiarrhythmic Agent may be selected for one objective but not the other.
Lanoxin may offer useful rate control in selected patients. Its limitation is the need for careful dosing, monitoring and interaction review.
Clinical Selection Factors
Doctors consider resting and exertional heart rate, blood pressure, ejection fraction, kidney function, electrolyte status and symptoms. Calcium channel blockers may not suit every patient with reduced cardiac function, while digoxin may not provide sufficient exertional rate control for some people.
What doctors say
A clinician would expect Lanoxin to support cardiac contraction or help control ventricular rate in selected patients when used as prescribed. Consistent dosing and careful monitoring are important because the therapeutic margin is narrow. Consult a physician if the prescribed plan is unclear or concerns arise during treatment.
Comparison
Common questions
Can Lanoxin be combined with medicines or supplements?
Health Canada materials updated in 2025 support medication reconciliation for digoxin because quinidine, selected calcium channel blockers, spironolactone, Lithium, antacids and supplements can affect exposure or cardiac conduction. The combination is not automatically forbidden, but it may require dose review, ECG assessment or blood testing. Provide a complete list of medicines and supplements before adding or stopping anything.
Can Lanoxin tablets be split, crushed or chewed?
The EMA product information available in 2025 describes oral digoxin administration and formulation-specific handling. Do not crush or chew a Lanoxin tablet unless the prescriber or pharmacist has confirmed that the specific tablet can be altered. Splitting can also create an inaccurate dose if the tablet is not designed for equal division.
Is Lanoxin suitable for older adults?
WHO cardiovascular medicine guidance available in 2025 recognises age and kidney function as important factors in medicine selection and monitoring. Older adults may clear digoxin more slowly and may be more vulnerable to dehydration, electrolyte changes, dizziness and falls. Prescribers often use a more cautious assessment of kidney function, body size, symptoms and interacting medicines.
How long does a Lanoxin course last, and is long-term use acceptable?
The EMA product information available in 2025 describes digoxin as treatment that may continue when clinical benefit remains greater than the risks. Some patients use it for long-term heart-failure or rate-control management, while others need a change because their rhythm, kidney function or treatment plan changes. Duration should be reviewed clinically rather than stopped abruptly.
Do diet, exercise or daily habits affect Lanoxin treatment?
Health Canada clinical information from 2025 supports attention to hydration and electrolyte balance during digoxin treatment. Vomiting, diarrhoea, poor fluid intake and major changes in diet can affect the risk of adverse effects, while exercise-related symptoms may reveal inadequate rate control. Avoid making large changes to supplements, electrolyte products or strenuous activity without discussing the cardiac treatment plan.
What should I do if the expected result does not come?
The FDA prescribing information current before 2026 states that treatment response must be assessed through symptoms, heart rate, ECG findings and clinical review rather than by increasing digoxin independently. Contact the prescriber if breathlessness, swelling, fatigue or rapid heart rate persists. Seek urgent help for fainting, collapse, severe palpitations, confusion or suspected overdose.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Lanoxin Forms and Strengths
Lanoxin tablets are oral preparations. Digoxin may also exist in paediatric, oral-drop or injectable forms in jurisdictions where those presentations are authorised, but the route and strength must match the prescription.
| Formulation | Route and clinical point | Handling concern |
|---|---|---|
| Lanoxin tablets | Oral administration for individually selected treatment | Strengths are not interchangeable without prescriber direction |
| Lanoxin oral drops or Lanoxin (Paediatric) | Oral liquid use when authorised | Household teaspoons are unsuitable for precise measurement |
| Lanoxin ampoules or IV digoxin | Intravenous administration by healthcare professionals | Prior cardiac glycoside exposure must be reviewed first |
Oral Tablet and Oral-Drop Formulations
Lanoxin Tablet treatment is taken by mouth. Lanoxin oral drops require an accurate measuring device, such as the supplied device or a pharmacy-provided oral syringe. A kitchen teaspoon can hold a variable volume and may cause a serious measuring error.
Injectable and Intravenous Digoxin
IV digoxin is administered in a clinical setting. Before Lanoxin ampoules are used, clinicians must account for previous oral or injectable cardiac glycoside exposure. Giving an intravenous loading regimen without reviewing recent exposure can raise the risk of accumulation and toxicity.
Lanoxin Strength Selection
A lower strength does not make self-directed dose changes safe. Lanoxin strength selection is based on the treatment purpose, kidney function, body weight, age, electrolyte status, response and interacting medicines.
Lanoxin Storage and Handling
Store Lanoxin Tablet according to the dispensing directions and the applicable product monograph. Protect it from excess heat and moisture, keep it in a secure child-resistant location and dispose of unused medicine through an approved medication-disposal route.
Customer Feedback on Lanoxin
the prescribed digoxin dose, during his treatment, for rate control in atrial fibrillation. He said the treatment helped at rest, while exertion still caused a fast heartbeat, so his clinician reviewed the broader rate-control plan.
the prescribed digoxin dose, several weeks, and described a mixed experience during treatment. Appetite loss and mild nausea appeared during dehydration, and the symptoms improved after assessment and medication review.
the prescribed Lanoxin dose, long term, and found the routine manageable. He said the most useful change was keeping an updated medicine list after another prescription was added.
Sources
- Health Canada (2024). Canadian product monograph for Lanoxin (digoxin).
- Cochrane (2020). Digoxin for heart failure and sinus rhythm.